Skip to main content
. Author manuscript; available in PMC: 2021 Nov 1.
Published in final edited form as: Pract Radiat Oncol. 2020 Feb 13;10(6):e495–e507. doi: 10.1016/j.prro.2020.01.012

Figure 1.

Figure 1

Case 1: Patient selection for hypofractionated dose escalation in locally advanced pancreatic cancer. A 2.9-cm mass extends from the head of the pancreas surrounding the celiac axis and abutting the superior mesenteric artery by 180°. No lymphadenopathy is appreciated. After neoadjuvant chemotherapy, the patient maintained a stable pancreatic head mass with continued encasement of the celiac axis and abutment of the superior mesenteric artery. In addition, magnetic resonance imaging revealed probable abutment of the common hepatic and splenic artery, superior mesenteric vein, and splenoportal confluence.